Novozymes A/S – (NASDAQ:NVZMY) has been assigned an average broker rating score of 3.00 (Hold) from the one analysts that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a hold rating.
Brokers have set a 12 month consensus price target of $48.38 for the company, according to Zacks. Zacks has also assigned Novozymes A/S – an industry rank of 98 out of 265 based on the ratings given to its competitors.
A number of brokerages have recently issued reports on NVZMY. Zacks Investment Research cut shares of Novozymes A/S – from a “hold” rating to a “sell” rating in a report on Thursday, August 25th. Berenberg Bank began coverage on shares of Novozymes A/S – in a report on Tuesday, September 27th. They set a “sell” rating for the company. Finally, Deutsche Bank AG began coverage on shares of Novozymes A/S – in a report on Friday, October 7th. They set a “hold” rating for the company.
Novozymes A/S – (NASDAQ:NVZMY) traded up 0.68% on Friday, reaching $42.71. 2,397 shares of the company’s stock traded hands. The company’s 50 day moving average is $43.63 and its 200-day moving average is $46.03. Novozymes A/S – has a 52-week low of $37.98 and a 52-week high of $49.55. The stock has a market cap of $12.83 billion and a price-to-earnings ratio of 29.87.
Novozymes A/S – Company Profile
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions.